Total Payments
$889.20
2024 Payments
$108.66
Companies
11
Transactions
32
Medicare Patients
795
Medicare Billing
$81,511
Payment Breakdown by Category
Food & Beverage$889.20 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $889.20 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $336.00 | 10 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $170.24 | 3 | $0 (2023) |
| ABBVIE INC. | $158.98 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $43.74 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $42.74 | 2 | $0 (2023) |
| TerSera Therapeutics LLC | $38.51 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.45 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $23.19 | 1 | $0 (2023) |
| BioXcel Therapeutics, Inc. | $18.49 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $15.55 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.66 | 5 | ABBVIE INC. ($80.21) |
| 2023 | $215.36 | 11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($43.74) |
| 2022 | $312.34 | 9 | Janssen Pharmaceuticals, Inc ($150.41) |
| 2021 | $252.84 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($213.47) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Gastroenterology | ||||||
| 10/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Gastroenterology | ||||||
| 10/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/25/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Oncology | ||||||
| 08/10/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/08/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Oncology | ||||||
| 05/22/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Cardiovascular | ||||||
| 04/17/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $126.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 232 | 367 | $243,298 | $25,857 |
| 2022 | 3 | 82 | 145 | $84,453 | $7,985 |
| 2021 | 6 | 324 | 434 | $305,233 | $29,911 |
| 2020 | 6 | 157 | 243 | $172,521 | $17,758 |
Total Patients
795
Total Services
1,189
Medicare Billing
$81,511
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 118 | $84,724 | $9,490 | 11.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 163 | $81,500 | $8,780 | 10.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 63 | 65 | $47,905 | $5,096 | 10.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $29,169 | $2,491 | 8.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 97 | $49,037 | $4,654 | 9.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 26 | $19,015 | $1,783 | 9.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 21 | 22 | $16,401 | $1,548 | 9.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 89 | 165 | $84,561 | $8,189 | 9.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 70 | 104 | $77,074 | $7,458 | 9.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 86 | 86 | $65,679 | $6,464 | 9.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 28 | $40,306 | $4,040 | 10.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 37 | 37 | $19,148 | $1,923 | 10.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $18,465 | $1,837 | 9.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 107 | $54,836 | $5,741 | 10.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 53 | $39,278 | $4,082 | 10.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 38 | 39 | $29,785 | $3,098 | 10.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 15 | 15 | $19,784 | $2,052 | 10.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $21,593 | $2,031 | 9.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 14 | 14 | $7,245 | $753.76 | 10.4% |
About Amanda Johnson, ACNP
Amanda Johnson, ACNP is a Acute Care healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245457670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Johnson, ACNP has received a total of $889.20 in payments from pharmaceutical and medical device companies, with $108.66 received in 2024. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($889.20).
As a Medicare-enrolled provider, Johnson has provided services to 795 Medicare beneficiaries, totaling 1,189 services with total Medicare billing of $81,511. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Nurse Practitioner
- Location Albuquerque, NM
- Active Since 04/19/2007
- Last Updated 04/27/2024
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1245457670
Products in Payments
- XARELTO (Drug) $170.24
- JARDIANCE (Drug) $152.81
- SPIRIVA RESPIMAT (Drug) $119.20
- DALVANCE (Drug) $78.77
- IMBRUVICA (Drug) $60.29
- OFEV (Drug) $49.99
- LifeVest (Device) $43.74
- XIFAXAN (Drug) $42.74
- Zoladex (Drug) $38.51
- FRUZAQLA (Drug) $28.45
- ELIQUIS (Drug) $23.19
- EPKINLY (Drug) $19.92
- IGALMI (Drug) $18.49
- VERQUVO (Drug) $15.55
- STIOLTO RESPIMAT (Drug) $14.00
- MYRISK (Device) $13.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Albuquerque
Catherine Mahoney, Cnp, CNP
Acute Care — Payments: $6,655
Acute Care $6,655
Christina Parks, Cnp, CNP
Acute Care — Payments: $6,544
Acute Care $6,544
Samantha Matteucci, Acnpc-Ag, ACNPC-AG
Acute Care — Payments: $6,193
Acute Care $6,193
Taryn Denezpi, Acnpc-Ag, ACNPC-AG
Acute Care — Payments: $5,127
Acute Care $5,127
Mrs. Isabel Torres, Cnp, CNP
Acute Care — Payments: $4,602
Acute Care $4,602
Ms. Pamela Parker, Arnp, ARNP
Acute Care — Payments: $3,537
Acute Care $3,537